Travere Therapeutics Reports Record FILSPARI Performance in 4Q 2025, Advances Regulatory and Clinical Milestones Ahead of 2026 Travere Therapeutics a biopharmaceutical company focused on developing and delivering transformative therapies for…
Compass Pathways partners with Radial Health to inform scalable COMP360 psilocybin delivery models and patient experience innovation across U.S. psychiatry clinics. Compass Pathways Radial collaboration marks a calculated step in…
ResearchAndMarkets.com has announced the addition of a new report titled “Europe Image-Guided Drug Delivery Market: Focus on Technology Type, Application, End User, and Country Analysis (2025–2035).” The report provides a…
Introductory EU Veterinary Drug Safety Course (Mar 2026) The “Introduction to Veterinary Pharmacovigilance Training Course (March 9–10, 2026)” has been added to the growing portfolio of professional training programs available…
FDA Clears RevBio® to Begin Clinical Trial of Regenerative Bone Glue in Dentistry RevBio, a biomedical company focused on developing regenerative biomaterials, announced that it has received approval from the…
Global Von Willebrand Disease Treatment Market Poised for Strong Growth Through 2032, Driven by Biologic Innovation and Personalized Care ResearchAndMarkets.com has added the comprehensive report “Von Willebrand Disease Treatment Market…
Global Women’s Digital Health Market Forecast 2025–2032 Added to ResearchAndMarkets.com ResearchAndMarkets.com has announced the addition of its latest industry report, “Women’s Digital Health Market – Global Forecast 2025–2032,” offering an…
HealthStream Expands Workforce Ecosystem with Acquisition of MissionCare Collective, Strengthening Caregiver Career Networks Nationwide HealthStream, a leading healthcare technology company specializing in workforce development solutions, today announced the acquisition of…
PDUFA Date Extended for Aldeyra’s Reproxalap Dry Eye NDA Aldeyra Therapeutics a biotechnology company focused on the discovery and development of innovative therapies for immune-mediated and inflammatory diseases, has announced…
Natera and MEDSIR Partner on MiRaDoR Trial to Advance Genome-Guided Treatment Strategies in HR+/HER2- Breast Cancer Natera a global leader in cell-free DNA (cfDNA) testing and precision medicine, and MEDSIR…
Summit Therapeutics Issues Inducement Awards Pursuant to Nasdaq Listing a biopharmaceutical company focused on developing innovative therapies for serious diseases, today announced the issuance of inducement equity awards in the…
The American Headache Society® (AHS)—a leading professional organization committed to advancing the science, education, and clinical practice of headache and facial pain medicine—has announced plans to host the 2025 Scottsdale…